Glorious Sun Enterprises Ltd
F:GLV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glorious Sun Enterprises Ltd
F:GLV
|
HK |
|
B
|
Biofrontera AG
DUS:B8F
|
DE |
|
Bechtle AG
OTC:BECTY
|
DE |
|
B
|
Bechtle AG
XMUN:BC8
|
DE |
|
A
|
A2 Milk Company Ltd
OTC:ACOPY
|
NZ |
|
E
|
Ebara Corp
F:EAR
|
JP |
|
H
|
Heritage-Crystal Clean Inc
XBER:4IJ
|
US |
|
We. Connect SA
F:77P
|
FR |
|
A
|
Australis Capital Inc
F:AC4
|
US |
|
A
|
Appili Therapeutics Inc
OTC:APLIF
|
CA |
|
V
|
Vilkyskiu Pienine AB
XMUN:UDW
|
LT |
|
Aozora Bank Ltd
F:AON
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLV's stock price target?
Not Available
GLV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Glorious Sun Enterprises Ltd?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Revenue has been -13%. The projected CAGR for the next 11 years is 21%.
What is the Net Income forecast for Glorious Sun Enterprises Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 11 years is 6%.